Which Clinical Documentation AI Tools Are Health Systems Using?

Health systems across the country are launching enterprise-wide deployments of AI-powered clinical documentation tools. Hospital leaders agree that this technology reduces physician burnout, as well as allows physicians to have more meaningful and productive interactions with patients. The post Which Clinical Documentation AI Tools Are Health Systems Using? appeared first on MedCity News.

Read More

Novo Nordisk Commits $285M to Ascendis to Kick Off Alliance on Longer-Acting GLP-1 Drugs

The Novo Nordisk/Ascendis partnership’s lead program is once-monthly injectable semaglutide for type 2 diabetes and obesity. This product candidate will be developed with Ascendis Pharma technology that has already yielded two FDA-approved products with longer dosing intervals. The post Novo Nordisk Commits $285M to Ascendis to Kick Off Alliance on Longer-Acting GLP-1 Drugs appeared first…

Read More

Real-World Data Salvage Biohaven Drug, Paving Way for FDA Filing in Neuro Disease With No Approved Meds

Biohaven’s troriluzole, which initially failed a pivotal study in spinocerebellar ataxia, is now being readied for an FDA submission in this rare neurodegenerative disease. The turnabout is based on positive results from a new study that incorporated real-world evidence. The post Real-World Data Salvage Biohaven Drug, Paving Way for FDA Filing in Neuro Disease With…

Read More

Healthcare AI Is Only As Good As the Systems That Govern It

AI doesn’t just demand better processes. It requires a complete redesign of traditional healthcare operations for a new level of precision, traceability, and governance. A new operating model that the vast majority of healthcare organizations simply aren’t built around today. The post Healthcare AI Is Only As Good As the Systems That Govern It appeared…

Read More